Nevro

+$0.13 (+0.30%) Today

$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Nevro and other ETFs, options, and stocks.

About NVRO

Nevro Corp. engages in the provision of medical devices. The firm focuses on providing products that improve the quality of life of patients suffering from debilitating chronic pain.

CEO

D. Keith Grossman

Employees

945

Headquarters

Redwood City, California

Founded

2006

NVRO Key Statistics

Market cap

Price-Earnings ratio

—

Dividend yield

—

Average volume

746.76K

High today

$43.92

Low today

$43.00

Open price

$43.00

Volume

371.43K

52 Week high

$182.45

52 Week low

$41.74

NVRO News

BenzingaMay 20

Nevro's Return On Capital Employed Overview

Benzinga Pro data, Nevro NVRO reported Q1 sales of $87.84 million. Earnings fell to a loss of $34.33 million, resulting in a 13.91% decrease from last quarter.

Analyst ratings

Buy

23.1%

Hold

61.5%

Sell

15.4%

NVRO Earnings

-$1.10

-$0.73

-$0.37

$0.00

Q3 FY20

Q4 FY20

Q1 FY21

Q2 FY21

Q3 FY21

Q4 FY21

Q1 FY22

Q2 FY22

Estimated

— per share

Actual

Available Aug 3, After Hours

Why Robinhood?

Nevro Corp. engages in the provision of medical devices. The firm focuses on providing products that improve the quality of life of patients suffering from debilitating chronic pain. View more

Nevro's Return On Capital Employed Overview

62%

Nevro Corp. engages in the provision of medical devices. The firm focuses on providing products that improve the quality of life of patients suffering from debilitating chronic pain.